News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
142 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (26877)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (331)
2 (134)
3 (3)
4 (4)
5 (239)
6 (297)
7 (254)
8 (229)
9 (142)
10 (7)
11 (9)
12 (228)
13 (282)
14 (268)
15 (254)
16 (160)
17 (2)
18 (5)
19 (218)
20 (259)
21 (132)
22 (18)
23 (29)
24 (4)
25 (14)
26 (221)
27 (273)
28 (265)
29 (229)
30 (119)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Pharm Country
Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers, Including Children with Developmental Delays
Results from multi-institutional research collaboration published in Frontiers in Genetics journal
November 9, 2018
·
5 min read
Drug Development
Syros Announces Presentation of New Preclinical Data on SY-1365 in Treatment-Resistant HR-Positive Breast Cancer Cell Lines at San Antonio Breast Cancer Symposium
Syros Pharmaceuticals today announced that new preclinical data on SY-1365, its first-in-class selective cyclin-dependent kinase 7 (CDK7) inhibitor, will be featured in a Spotlight poster discussion session at the San Antonio Breast Cancer Symposium taking place December 4-8 in San Antonio.
November 9, 2018
·
4 min read
Policy
American College of Chest Physicians Disagrees with FDA Decision to Approve Over-the-Counter Epinephrine for the Treatment of Asthma
The American College of Chest Physicians (CHEST) is disappointed with the FDA’s decision to approve over-the-counter epinephrine (Primatene Mist HFA) for the treatment of asthma.
November 9, 2018
·
1 min read
Biotech Bay
UnitedHealthcare and Optum Take Action to Support People Affected by Wildfires in Northern California
UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking action to help people affected by the ongoing wildfires in parts of Butte county.
November 9, 2018
·
2 min read
Drug Development
Nektar Therapeutics Presents New Clinical and Preclinical Data for its Immuno-Oncology Pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nektar Therapeutics (Nasdaq: NKTR) announced today a presentation of new clinical and preclinical data for its I-O pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting.
November 9, 2018
·
15 min read
Policy
Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie’s Humira Sales Practices
Hagens Berman Sobol Shapiro LLP reminds investors in AbbVie Inc. (NYSE: ABBV) of the Firm’s ongoing investigation of AbbVie’s Humira sales practices.
November 9, 2018
·
2 min read
BioCapital
FDA Decision to Approve Primatene Mist Endangers Asthma Patients, According to Allergy & Asthma Network and Asthma Community Stakeholders
A group of asthma community stakeholders released a joint statement today expressing deep concern over the Food and Drug Administration’s (FDA) decision to approve Primatene Mist as an over-the-counter (OTC) treatment for mild, intermittent asthma.
November 9, 2018
·
6 min read
Business
Oxford Immunotec Reports Third Quarter 2018 Financial Results
Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced third quarter 2018 financial results.
November 9, 2018
·
9 min read
Revolutionizing the production of novel diagnostics with of cost-effective Roll-to-Roll imprinting
SCIENION AG today announced that the pioneering work of the EU-funded R2R Biofluidics project has been awarded with the Austrian Fast Forward Award 2018.
November 9, 2018
·
3 min read
CannTrust to Hold Third Quarter 2018 Financial Results Conference Call
CannTrust Holdings Inc. plans to release its financial results for the third quarter ended September 30, 2018 on Wednesday, November 14, 2018 after market close.
November 9, 2018
·
4 min read
Previous
6 of 15
Next